CN1064969C - Obtusatus arthrospira phycocyanin and its application - Google Patents

Obtusatus arthrospira phycocyanin and its application Download PDF

Info

Publication number
CN1064969C
CN1064969C CN94109295XA CN94109295A CN1064969C CN 1064969 C CN1064969 C CN 1064969C CN 94109295X A CN94109295X A CN 94109295XA CN 94109295 A CN94109295 A CN 94109295A CN 1064969 C CN1064969 C CN 1064969C
Authority
CN
China
Prior art keywords
phycocyanins
phycocyanin
cfu
health food
food composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94109295XA
Other languages
Chinese (zh)
Other versions
CN1117973A (en
Inventor
张媛贞
曾昭琪
李祥林
石玉洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94109295XA priority Critical patent/CN1064969C/en
Publication of CN1117973A publication Critical patent/CN1117973A/en
Application granted granted Critical
Publication of CN1064969C publication Critical patent/CN1064969C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention discloses new phycocyanin extracted from blunt-top arthrospira. The formula weight of the phycocyanin is 14500 dalton, the isoelectric point of the phycocyanin is 4.8, and the maximum spectral absorption value of the phycocyanin is 620mm. The phycocyanin is an oligomer composed of an alpha subunit and a beta subunit. The phycocyanin has a good health-care effect. The present invention also discloses a series of health-food compositions containing the phycocyanin and an application of the phycocyanin in the field of fluorescence detection.

Description

Obtusatus arthrospira phycocyanin and application thereof
The present invention relates to a kind of Phycocyanins, C-of novelty, more specifically, relate to the Phycocyanins, C-of obtusatus arthrospira, contain the composition of this Phycocyanins, C-, and uses thereof.
The formal name used at school of obtusatus arthrospira is Arthrospira platensis, is commonly called as spirulina, is a kind of valuable plant protein resource.It contains nutritive substances such as rich in protein, β-Hu Luobusu.
It is raw material with the blue green alga-spiral alga that Chinese patent application 89100036.4 discloses a kind of, through levigate, and leaching, hydrolysis makes the protein amino acid solution, prepares the method for blue transparent beverage again with this solution.
Chinese patent application No.94112205.0 is entitled as " artrospira spirulina health food composition and method for making thereof ", discloses a kind of food compositions that contains the artrospira spirulina enzymatic hydrolyzed extract, and method for making.
1986, the Schwartz and the Shklar of U.S. Harvard Medical School found after deliberation, and the algae egg white mixture that Oscillariaceae extracts from the algae of a kind of unknown kind of Spirullina has restraining effect to some cancer cells, and function such as antifatigue is arranged.Also the someone is applied to anti-ageing and treatment AIDS disease aspects such as (AIDS).
In a word, do not see the relevant report that from the algae of Spirullina, extracts Phycocyanins, C-in the prior art, especially do not extract the report of Phycocyanins, C-from obtusatus arthrospira.
An object of the present invention is to provide a kind of protein of novelty, the Phycocyanins, C-that this protein gets for extraction separation from obtusatus arthrospira.
Another object of the present invention provides a kind of method for making of Phycocyanins, C-.
The 3rd purpose of the present invention provides a series of food compositions that contain Phycocyanins, C-.
The 4th purpose of the present invention provides the purposes of this cyanophycin aspect fluoroscopic examination.
To achieve these goals, the inventor studied through the several years, extracted a kind of Phycocyanins, C-of novelty from obtusatus arthrospira, it is characterized in that, the molecular weight of this Phycocyanins, C-is about 14500 dalton, iso-electric point is 4.8, its maximum spectral absorption value is 620mm, in addition, and the oligomer that this Phycocyanins, C-is made up of α and β subunit, wherein α and β subunit are the polypeptide chains that is made of 160-180 amino acid, and two subunits have homology.
The present invention also provides and has contained a series of food compositions of an amount of Phycocyanins, C-as main component.
The present invention also provides the application of Phycocyanins, C-aspect fluoroscopic examination.
Extraction of the present invention from the Phycocyanins, C-of artrospira spirulina be some alga cells important catch photopigment albumen, closely related because of its splendid health-care effect again with the human lives.Phycocyanins, C-can be joined in the foodstuffs compositions as effective constituent, make different protective foodss.Food compositions not only can be made various people form common and commonly used like this, and can play splendid health-care effect.
Artrospira spirulina originates in Africa, environment such as happiness high temperature, long day and high pH value.China did not have this kind of plant originally.1978, the inventor at first tamed and dociled from U.S.'s introducing algae kind and educates.By discovering of aspects such as ultrastructure, be " spirulina " by domestic and international misnomer, reality is obtusatus arthrospira (Arthrospira platensis).About the cultural method and the condition of artrospira spirulina, and the method for results artrospira spirulina, can be referring to the inventor on June 18th, 1994 application, application number No.94112205.0 is entitled as the patent application of " artrospira spirulina health food composition and method for making thereof ".
The whole process that the present invention extracts Phycocyanins, C-is as follows: cultivate artrospira spirulina, make the exsiccant artrospira spirulina after the results, through broken wall, the centrifugal crude extract that makes, crude extract is again through saltouing, dialysis, and steps such as ion exchange chromatography make purified Phycocyanins, C-.
More specifically, it is an amount of that the artrospira spirulina dry algae powder is added water, and (for 15~20 times of dry powder weight) → put-4 ℃ is freezing, and → 25 °~35 ℃ melt, and → freezing again melting repeated 3~5 times; (or carry out enzymolysis with enzyme) → centrifugal → abandon throw out gets supernatant liquor, and add ammonium sulfate and divide gold-plating, → abandon the lower sediment thing, get topper, through dissolving and dialysis → carry out ion exchange chromatography with the DEAE fibre columns, lyophilize obtains purified Phycocyanins, C-.
Wherein, breaking cell wall can adopt methods such as freeze-thaw method or enzymolysis process to carry out.
Wherein, the enzyme of selecting for use during enzymolysis can be one or more of (but being not limited to) following enzyme: cellulase, papain, Traumanase, aspergillus oryzae, Monascus ruber, amylase, saccharifying enzyme, helicase etc.Enzymolysis is generally at pH3-8, and temperature 20-50 ℃ was carried out 18-24 hour, and enzymatic hydrolysis condition also can be by the condition of manufacturer's suggestion.
Frozen-thaw process can carry out one or many.Generally with repeatedly, especially 3-5 time for well.
The Phycocyanins, C-that makes finds that after deliberation its spectral response curve is as follows: obtained the maximum absorption is 620mm, and the fluorescence maximum value is 640mm.
This shows that Phycocyanins, C-absorption spectrum and green plants photosynthesis spectrum are complementary just, and this is wide to distributing, and originally productivity lacks the algae of chlorophyll b greatly, and it is important more to seem.
The absorption spectrum of Phycocyanins, C-in the aqueous solution is more hypsochromic slightly than peak value (λ max) in live body, its spectral shape and intensity depend primarily on the character of chromophore, quantity and state of aggregation, in the general chromophore 4 pyrroles systems conjugated double bond the more, λ max is more to red shift; (α, absorption spectrum β) is α, the superposition that beta subunit absorbs respectively, but further polymerization then can cause the red shift of long wave absorption peak, and increase with uptake factor (ε M).
Phycocyanins, C-is rare fluorescent in life cell, and they in a single day are released in the solution and when giving an amount of illumination, PE just sends brown fluorescent, and PC then sends red fluorescent.Relatively absorption and the emmission spectrum of PE, PC, AP and Chla between the PE-PC, all have stronger absorption to overlap between the PC-Ap and between the Ap-Chla, and the pass order of this hint energy between these photosynthetic pigments is: PE-PC-Ap-Chla.
Structure to Phycocyanins, C-is furtherd investigate, and finds that Phycocyanins, C-generally forms oligomer by α and beta monomers, wherein the polypeptide chain be made up of about 160-180 amino acid of α and β subunit.
The homology of Phycocyanins, C-subunit also showing on the higher level on similar polymerization behavior and the polymerizable molecular conformation, its step by step polymerization process established architecture basics for its transmission ofenergy function of in cell, undertaking.
Phycocyanins, C-behind the purifying all obtains single colour band with polyacrylamide gel (PAGE) electrophoresis and isoelectric focusing, its iso-electric point (IEP) value is respectively 4.8, Phycocyanins, C-by the visible obtusatus arthrospira of 12%SDS polyacrylamide gel (SDS-PAGE) electrophoresis is made up of α and two subunits of β, and its molecular weight is 14500.
The amino acid of Phycocyanins, C-is formed and content, and after measured, data are listed in table 1.
Table 1.
The amino acid of Obtusatus arthrospira phycocyanin is formed and content (%)
The amino acid Phycocyanins, C-
Aspartic acid Asp 6.15
Threonine Thr 6.56
Serine Ser 6.29
L-glutamic acid Glu 5.45
Glycine Gly 11.48
L-Ala Ala 10.13
Gelucystine Cys 5.37
Xie Ansuan Val 6.91
Methionine(Met) Met-
Isoleucine Ile 6.29
Leucine Leu 5.48
Tyrosine Tyr 5.70
Phenylalanine Phe 5.46
Methionin Lys 5.58
Proline(Pro) Pro-
Arginine Arg 4.10
Histidine His-
Tryptophane Try ND *
* undetermined.
As can be seen from Table 1, dicarboxylic amino acid (aspartic acid, L-glutamic acid) contained in the Phycocyanins, C-is higher with the ratio of basic aminoacids (Methionin, arginine), so its iso-electric point (IEP) is lower, is 4.8.In addition, Phycocyanins, C-lacks methionine(Met), proline(Pro) and Histidine.
Surprisingly, the inventor finds that Phycocyanins, C-has extremely important health-care effect: it has higher erythropoietin activity, the CFU-E colony is formed to have stronger hormesis (table 2) simultaneously.
Table 2.
Obtusatus arthrospira phycocyanin is to the influence of tire mouse liver cell CFU-E in late period
Sample Dosage The CFU-E colony is counted Counts of CFU-E colony (/ 2 * 10 4FLC) Suitable EPO unit Than Specific activity alive (μ/mg)
Blank Control (1640) 69 ±28.5
Standard EPO 62.5mu 125.0mu 250.0mu 500.0mu 1000.0mu 97±29.4 128±53.2 165±67.3 223±54.7 283±77.9
Phycocyanins, C-C-Phycocyanin 12.5ng 271±60.4 850 68000
As seen from Table 2, Spirulina phycocyanin has higher erythropoietin activity, the CFU-E colony is formed to have stronger hormesis simultaneously.
Phycocyanins, C-is also influential to the formation of normal mouse CFU-GM.Data are listed in table 3.
The influence that the external adding Obtusatus arthrospira phycocyanin of table 3. forms normal mouse CFU-GM
Rank Group Dosage (μ/ml) The CFU-GM colony is counted CFU-GM (Colony/10 5BMC)
Control group Control (MCM) 0 119.67±6.1
C-PC+MCM 10 20 50 100 200 120.33±3.06 127.33±4.73 143.67±9.02* 175.33±5.14* * * 140.33±3.45*
SPP C-PC 100 100 0 0
Annotate: MCM mouse flesh conditioned medium (Conditioned Medium of micemusal)
C-PC: the Phycocyanins, C-that derives from artrospira spirulina.
X ± SD n=5*P<0.05**P<0.01***P<0.001 (compared with the control).
Observed 60Recovery situation behind the Co gamma-rays 5Gy irradiation small white mouse grain monosystem progenitor cell in 30 days, find, 1-5 days small white mouse grain list progenitor cell colonies after being subjected to photograph form minimum, began in the 10th day to recover, and giving abdominal injection Phycocyanins, C-test group mouse, its CFU-GM productive rate is significantly higher than control group.Illustrate that Obtusatus arthrospira phycocyanin can significantly promote to be subjected to shine the proliferation and differentiation of mouse grain monosystem progenitor cell.
In addition, Phycocyanins, C-forms also influential to extracorporeal irradiation medullary cell CFU-GM.
Normal mouse marrow is made behind the single cell suspension after the Phycocyanins, C-of different concns is hatched warp 60Carry out CFU-GM behind the Co gammairradiation again and cultivate, it the results are shown in Table 4.
Table 4.
The influence of Obtusatus arthrospira phycocyanin to being subjected to form according to bone marrow cells in mice CFU-GM
Group Group Dosage Dose (μ g/ml) The CFU-GM colony is counted CFU-GM (Colony/10 5BMC) P
Contrast Control 0 51±4.48
Phycocyanins, C-C-PC 10 50 100 200 60.6±2.93 72±5.83 88.4±5.37 69±2.24 <0.01 <0.001 <0.001 <0.001
As can be seen from Table 4, the medullary cell of hatching with the Phycocyanins, C-of different concns forms the CFU-GM productive rate apparently higher than control group, this shows that Phycocyanins, C-can improve the capability of resistance to radiation of medullary cell.
Also studied the influence of Phycocyanins, C-to the mice serum colony stimulating activity.
Get normal mouse, the abdominal injection Phycocyanins, C-, administration was got blood from eyeball after 1~10 day, and (Colony stimulating factor, CSF) CFU-GM is cultivated in the source to gained serum as G CFS.Data are listed in table 5.
Table 5.
Obtusatus arthrospira phycocyanin is right
The influence of mice serum colony-stimulating vigor
Group Group Administration time (my god) The CFU-GM colony is counted CFu-GM (Colony/10 5BMC) aSerum bSerum+MCM P
Control group
Control - 70±1 113±9.17
Phycocyanins, C-C-PC 1 5 10 86.33±3.05 125±2 98±3.61 137±5.29 109.33±2.54 138.67±1.54 >0.05 <0.05 <0.05
Annotate: a. final concentration 10%
B. final concentration 5%
From mouse boosting cell generation the influence that G CFS caused of Phycocyanins, C-, also can find out the health-care effect of Phycocyanins, C-to mitogenstimulated.
Normal mice by intraperitoneal injection Phycocyanins, C-is after 5 days, and extracting spleen cell was by 5 * 10 in the 6th day 6Ml concentration is incubated in the serum-free medium that contains 5 μ g/ml ConA, cultivate back centrifuging and taking supernatant, detect the colony stimulating activity of supernatant liquor, the same Phycocyanins, C-that adds different concns in the spleen cell cultures system, gained supernatant liquor carry out colony stimulating activity and measure.The detected result of the spleen cell cultures supernatant liquor of two kinds of methods preparation sees Table 6 and table 7.
Table 6.
Inducing mouse spleen in the Obtusatus arthrospira phycocyanin body
Produce the influence of G CFS
Group Group The CFU-GM colony is counted CFU-GM (Colony/10 5BMC)
aSF-SCCM bF-SCCM+MCM
Control group Control 71.73±3.49 106.47±12.68
Phycocyanins, C-C-PC 101.87±9.98*** 126.2±7.98**
A. final concentration 10%
B. final concentration 5%
SF-SCCM serum-free splenocyte conditioned medium
* P<0.01, * * * P<0.001 (compared with the control)
By table 6 as seen, the abdominal injection Phycocyanins, C-, the inducing mouse splenocyte produces G CFS more significantly.
Table 7.
The external evoked mouse spleen cell of Obtusatus arthrospira phycocyanin
Produce the influence of G CFS
Group Group Dosage Dose (μ g/ml) The CFU-GM colony is counted CFU-GM (Colony/10 5BMC) aF-SCCM bSF-SCCM+MCM
Control group Control - 81.67±5.03 115±6
Phycocyanins, C-C-PC 10 50 100 85.67±3.05 106.67±3.5l** 117±4** 97.67±3.05 118.33±4.17 142.33±3.05**
A. final concentration 10%
B. final concentration 5%
* P<0.05, * * P<0.01, * * * P<0.001 (compared with the control)
As can be seen from Table 7, external adding Phycocyanins, C-more significantly the inducing mouse splenocyte produce G CFS.
In addition, by Phycocyanins, C-to mouse CFU-E (CFU-E, BFU-E) influence of proliferation and differentiation.
(a) influence that normal mouse and anemia mice CFU-E and BFU-E are formed.
Normal mice by intraperitoneal injection Phycocyanins, C-5 days, carried out the cultivation of CFU-E and BFU-E on the 6th day, experimental result shows that Obtusatus arthrospira phycocyanin can improve CFU-E of mouse and the productive rate of BFU-E by the utmost point significantly, illustrates that Obtusatus arthrospira phycocyanin can promote the small white mouse erythroid hematopoiesis.
Normal small white mouse cervical vertebra dislocation is put to death, take out femur and make single cell suspension, do the cultivation of CFU-E, culture system replaces the Phycocyanins, C-that directly adds different concns when EPO or EPO exist with the Phycocyanins, C-of different concns and cultivates CFU-E, make blank with 1640, only adding EPO is normal control, listed in result such as the table 8.Hence one can see that, and Phycocyanins, C-has direct hormesis to CFU-E, promotes the formation of CFU-E colony.Phycocyanins, C-can significantly improve the productive rate (comparing with the normal control group) of CFU-E when existing simultaneously with EPO.
Table 8.
The influence that external adding Obtusatus arthrospira phycocyanin forms CFU-E
Group Group Dosage Dose (μ g/ml) The CFU-E colony is counted CFU-E clone counting (Colony/5 * 10 4BMC)
Control group I Control (I) EPO (+) control group I Control (I) EPO (-) 152±11.3 51±17.2
(EPO) C-PC (EPO) for Phycocyanins, C- 0.015 1.000 10.00 50.00 100.00 147±17.9 172.2±14.8* 261.3±15.7* * * 227.7±19.6* * * 156.9±20.4
Phycocyanins, C-(+EPO) C-PC (+EPO) 0.015 1.000 10.00 50.00 100.0 244.5±13.7* * 273.3±18.2* * * 297.8±20.7* * * 301.3±22.7* * * 279.9±27.7* * *
EPO erythropoietin (Erythropoietin) * P<0.05, * * P<0.01, * * * P<0.001, ((I) compares with control group)
In the BFU-E culture system, be that the Phycocyanins, C-of 0.015 μ g/ml replaces EPO or BPA with final concentration, or replace EPO and BPA simultaneously, and EPO and BPA add Phycocyanins, C-when existing simultaneously and cultivate BFU-E.Other establishes 4 groups of contrasts, the normal control that EPO and BPA add simultaneously, and one of them adding of EPO and BPA and EPO and BPA do not add.Experimental result such as table 9.
The influence that Obtusatus arthrospira phycocyanin forms BFU-E under table 9. different condition
Group Group Control group Control Experimental group
1 2 3 4 5 6
EPO BPA * C-PC HS L-glutamine mercapto alcohol methylcellulose RPMI-1640 + + - + + + + + - + - + + + + + + - - + + + + + - - - + + + + + - + - + + + + + - + + + + + + + - - - + + + + + - - + + + + + + + + - + + + + + + + + + + + + +
BFU-E clone counting (clone/5 10 4BMC) 30.7 ±5.4 13.4 ±3.7 0 0 21.3** ±5.1 31.8** ±7.4 0 5.1 ±4.3 (**) 43.3 ±5.5 (**) 51.2 ±7.7
A. final concentration 0.015 μ g/ml (* *) P 0.01, I compares with control group, and * * P 0.01 compares with control Group II.
The BPA burst promoting factor
The HS horse serum
As can be seen from Table 9, adding Phycocyanins, C-BFU-E productive rate does not descend identical with normal control, and when no BPA existed, BFU-E can not form, but after having added Phycocyanins, C-, can form few colony.Therefore can know the activity that Phycocyanins, C-has EPO by inference, and the effect of certain BPA sample is arranged.
The mouse warp 60Form Anemia behind Co gammairradiation and the abdominal injection phenylhydrazine hydrochloride, its CFU-E and BFU-E productive rate significantly descend.But no matter be according to preceding or according to after give mouse peritoneal injection Phycocyanins, C-, CFU-E of mouse and BFU-E productive rate are significantly higher than control group.
The health-care effect that the Phycocyanins, C-of purifying from obtusatus arthrospira in sum, has mainly shows:
Have higher erythropoietin activity, the CFU-E colony is formed have stronger hormesis simultaneously: can promote and acceleration is subjected to 60The leukocytic recovery of Co gamma-rays (5Gy) irradiation back small white mouse; Can improve small white mouse bone marrow nucleated cell number more significantly, can resist or significantly opposing irradiation and make its recovery reach normal value to the damage of small white mouse bone marrow nucleated cell; Promote the proliferation and differentiation of mouse grain monosystem progenitor cell; The inducing mouse splenocyte produces G CFS significantly; To the promoter action that is formed with of mouse bone marrow cells matrix progenitor cell, that is to marrow microcirculation has certain influence.
So, thisly can promote immunity system in order to develop, the natural protein of opposing various diseases, on experiment basis, the inventor further provides a series of health food compositions that contain Phycocyanins, C-as active princlple.
Health food composition generally contains 95% Phycocyanins, C-and 5% water and/or auxiliary material.
Wherein a kind of health food composition is capsule or tablet, and it consists of 95% Phycocyanins, C-, and 5% auxiliary material.
Another kind of health food composition is a beverage, and it consists of 7% Phycocyanins, C-, 91% water and 2% auxiliary material.
The third health food composition is an oral liquid, and it consists of 30% Phycocyanins, C-, 68% water and 2% auxiliary material.
In the present invention, " auxiliary material " refers to constitute the complementary raw material of health food composition, i.e. other secondary material except that Phycocyanins, C-and water specifically comprise:
1. cereal; Starch; Dextrin;
2. vegetable puree;
3. sweeting agent-stevioside or protein sugar, or another name for sugar etc.;
4. essence;
5. carboxymethyl cellulose;
6. gum arabic; Tragakanta etc.
Adopt Phycocyanins, C-as a kind of specific health-care components in the food compositions, when making health food composition, method, technology and the equipment that can adopt food-processing and making field to know, and can add other known compositions with health-care effect, more balancedly to bring into play health-care effect.
In addition, than protein, because Phycocyanins, C-effective high fluorescent productive rate in the pH of broad value scope as a kind of novelty; Their fluorescent does not disappear because of the existence of other biomolecules; Can be better molten between water; Therefore stabilizer pole and can preserve reason such as long period all when existing with the liquid or solid state can be used for immunodetection, the fluorescent microscopy, etc. the aspect.
Below in conjunction with embodiments of the invention, set forth the present invention in further detail.
Unless dated especially, otherwise all per-cent all is weight percent.Embodiment 1
The making embodiment 1A of Phycocyanins, C-crude extract
Get dry algae powder 100g and add 2000ml phosphoric acid buffer (pH7.3) and add amylase 1.5g, put in 35 ℃ of water-baths 30 minutes, fully stir 30 minutes after, put quick-frozen under-20 ℃ of environment, take out after waiting to form ice cube, put in 35 ℃ of water-baths and thaw, restir 30 minutes, quick-frozen again, three times so repeatedly, after the freeze thawing, centrifugal 30 minutes of 4 ℃ of 1000rpm, collect supernatant liquor, this is crude extract.Embodiment 1B
In the 100g dry algae powder, add 25 ℃ of distilled water pH7.3 of 2000ml and add amylase 1.2g, put in 37 ℃ of water-baths 45 minutes, stir that quick-frozen becomes ice cube after 30 minutes, thaw under 30 ℃ of conditions, stir quick-frozen again in 40 minutes.Triplicate, 1500rpm is centrifugal, gets supernatant liquor, (this is crude extract).Embodiment 1C
Get the 100g dry algae powder and add saccharifying enzyme 1g, add 20 ℃ of distilled water 2000ml pH7.3 and put in 27 ℃ of water-baths 30 minutes, stirred 30 minutes, quick-frozen is thawed under 20 ℃ of conditions, quick-frozen, and 2000rpm is centrifugal behind the multigelation three times, gets supernatant liquor, promptly gets crude extract.Embodiment 1D
Get dry algae powder 10g and add 200ml phosphoric acid buffer pH7.3 induction stirring 30 minutes, put in-20 ℃ of environment 12 hours, taking-up is put in 37 ℃ of water-baths and is thawed, restir 30 minutes freezes to take out after 12 hours again and thaws, and stirs, freezing, so behind the multigelation three times, centrifugal 30 minutes of 4 ℃ of 1000rpm collect supernatant liquor (this is a crude extract).Embodiment 2 Phycocyanins, C-s separate, purifying:
The crude extract that obtains among the embodiment 1 is diluted one times with distilled water, last DEAE52 cellulose column (3 * 18cm).This capital is used 10mM pH7.3 phosphoric acid buffer balance in advance, and 280nm detects, treat that crude extract all enters fibre columns after, wash post to baseline with same damping fluid, use the phosphoric acid buffer of 10mM pH8.0 again instead, and add the Na-Cl of 0.3N and 0.6N, branch's wash-out and collection.
Get the elution peak of the NaCl of 0.3N, add solid ammonium sulfate to saturation ratio, 4 ℃ to leave standstill after 4 hours 2500rpm centrifugal, collecting precipitation adds water 10ml dissolving, and water is dialysed, change the dialyzate secondary, dialysis equilibrium spends the night in the phosphoric acid buffer of the most rearmounted 500ml 10mM pH7.3.
Liquid after the dialysis, the centrifugal precipitation of going of 2500rpm, (1.5 * 95cm) gel columns are used the phosphoric acid buffer balance of 10mM pH7.3 to supernatant liquor in advance with Seohade * G75 gel filtration column, once go up sample, with same buffer elution, fraction collection, and do CFU-E and electrophoretic analysis, lyophilize gets finished product.One of embodiment 3 health food compositions: the making of capsule (or tablet)
(1) prescription:
A. phycocyanin extract 56%, starch 4%, β dextrin 20%, Icing Sugar 20%;
B. phycocyanin extract 66%, β dextrin 4%, starch 30%;
C. phycocyanin extract 85%, β dextrin 5%, carboxymethyl cellulose 1%, dressing 9%;
D. phycocyanin extract 95%, β dextrin and carboxymethyl cellulose 5%
(its ratio: 85: 15)
(2) method for making:
Purifying Phycocyanins, C-powder+auxiliary material (by prescription) → kneading is agglomerating, feel suitably → 18 mesh sieves, sieve series become 80 ℃ of following drying in oven of particle → put → respectively by hand or machine be filled in the capsule → check (the weighing error must not greater than ± 0.1g → encapsulation → 60The Co width of cloth is penetrated sterilization → finished product;
Or the particle → compacting that will dry is in blocks, and → bag or not sugar coating → envelope (bag) dress → check → width of cloth are penetrated sterilization → finished product.(3) advantage
Phycocyanins, C-is comprised in the capsule; Can make its disintegration in stomach or intestines according to the requirement of using; It not only can effectively prevent its oxidation, and can better preserving property, effective ingredient, improve health-care effect.Embodiment 4
Two of health food composition: the making of beverage and oral liquid,
A. the dry Phycocyanins, C-50g that gets purification adds the 2.5g gum arabic, in dried mortar, grind well, once add the 25ml distilled water, wear into breast in the homogenizer rapidly, it is an amount of to add the stevioside aqueous solution then, slowly adds tragacanth mucilage (0.7g powder) again and adds water and make slurry in right amount, adds 0.1% potassium sorbate, add distilled water to 1000ml, with its filling bottle, the sterilization.
B Phycocyanins, C-70% Yelkin TTS 30g grinds to form breast in the homogenizer, it is an amount of to add the stevioside aqueous solution, continues emulsification and adds potassium sorbate 0.1%, adds distilled water to its filling bottle of 1000ml, sterilization.
C. Phycocyanins, C-30g, stevioside, citric acid is an amount of, and sterilization water makes into 100ml, the bottling disinfection.
The characteristics of oral liquid and beverage:
Fully natural green; Do not have any artificial color sugar-free and contain multiple amino acids and element and trace element.
Although, the present invention sets forth in conjunction with above specific embodiment, but, by reading specification sheets of the present invention and claims, those skilled in the art can fully understand feature of the present invention and advantage, and can under the prerequisite of purport of the present invention, make many modifications to specific embodiments of the invention, changes such as increase or deletion, but this falls within claims institute restricted portion of the application equally.

Claims (5)

1. Phycocyanins, C-matter, it is characterized in that, this protein extracts from obtusatus arthrospira, its molecular weight is 14500 dalton, iso-electric point is 4.8, and maximum spectral absorption value is 620nm, and the oligomer of being made up of α and β subunit, wherein α and β subunit are the polypeptide chains that is made of 160-180 amino acid, and two subunits have homology.
2. a health food composition is characterized in that, it contains Phycocyanins, C-as claimed in claim 1 as one of component.
3. a health food composition as claimed in claim 2 is characterized in that, this health food composition is capsule or tablet.
4. a health food composition as claimed in claim 2 is characterized in that, this health food composition is beverage or oral liquid.
5. the purposes of a Phycocyanins, C-as claimed in claim 1 is characterized in that, this Phycocyanins, C-is used for fluoroscopic examination, immunodetection and fluorescent microscopy.
CN94109295XA 1994-08-31 1994-08-31 Obtusatus arthrospira phycocyanin and its application Expired - Fee Related CN1064969C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94109295XA CN1064969C (en) 1994-08-31 1994-08-31 Obtusatus arthrospira phycocyanin and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94109295XA CN1064969C (en) 1994-08-31 1994-08-31 Obtusatus arthrospira phycocyanin and its application

Publications (2)

Publication Number Publication Date
CN1117973A CN1117973A (en) 1996-03-06
CN1064969C true CN1064969C (en) 2001-04-25

Family

ID=5033856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94109295XA Expired - Fee Related CN1064969C (en) 1994-08-31 1994-08-31 Obtusatus arthrospira phycocyanin and its application

Country Status (1)

Country Link
CN (1) CN1064969C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI626892B (en) * 2015-12-18 2018-06-21 旭海生物科技有限公司 Acrochaetium extract and extraction method thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1098707C (en) 1999-07-19 2003-01-15 齐清 Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose
CN101760492B (en) * 2008-12-24 2013-08-14 徐宝贞 Method for extracting algae glycoproteins
CN103304648A (en) * 2012-03-15 2013-09-18 大丰市赐百年生物科技有限公司 Purification technology of phycocyanin
CN102640933A (en) * 2012-04-17 2012-08-22 中国科学院烟台海岸带研究所 Phycocyanin microcapsule and preparation method of phycocyanin microcapsule
CN103044520B (en) * 2012-12-05 2014-08-06 中国科学院烟台海岸带研究所 Separation and purification method of arthrospira proteins
CN106267157B (en) * 2015-06-03 2020-03-13 远东生物科技股份有限公司 Composition for preventing or/and treating periodontal diseases and application thereof
CN108822188A (en) * 2018-07-27 2018-11-16 吉林大学珠海学院 A kind of protein extraction and isolation and purification method
FR3091640B1 (en) * 2019-01-11 2021-06-11 Fermentalg PHYCOCYANIN PURIFICATION PROCESS
FR3130842A1 (en) 2021-12-22 2023-06-23 CarbonWorks METHOD FOR CAPTURING PHYTOTOXINS IN A BIOLOGICAL REACTOR

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS626691A (en) * 1985-07-02 1987-01-13 Dainippon Ink & Chem Inc Phycocyanin pigment a from blue-green alga, production and use thereof
CN1035425A (en) * 1988-12-29 1989-09-13 江西师范大学 The manufacture method of blue green alga-spiral alga drink

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS626691A (en) * 1985-07-02 1987-01-13 Dainippon Ink & Chem Inc Phycocyanin pigment a from blue-green alga, production and use thereof
CN1035425A (en) * 1988-12-29 1989-09-13 江西师范大学 The manufacture method of blue green alga-spiral alga drink

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI626892B (en) * 2015-12-18 2018-06-21 旭海生物科技有限公司 Acrochaetium extract and extraction method thereof

Also Published As

Publication number Publication date
CN1117973A (en) 1996-03-06

Similar Documents

Publication Publication Date Title
CN1064969C (en) Obtusatus arthrospira phycocyanin and its application
JP5154964B2 (en) Contains royal jelly-degrading enzyme
CN1043722C (en) Process for preparing transparent royal jelly solution
CN102406052B (en) Anti-bacterial peptide hydrolysate of earthworm and feed comprising the same
CN1070056C (en) Method to accelerating growth of animal and powdered composite of microbe cells contraining killed fusiform bacillus of bacteria
CN104745665A (en) Collagen peptide with function of promoting bone growth as well as preparation method and application thereof
WO2018105919A2 (en) Pomegranate beverage containing marine collagen and method for manufacturing same
CN110117632B (en) Method for improving antioxidant stability of watermelon seed polypeptide by combining ultrasonic and double enzymolysis
CN1891711A (en) Method for preparing physiological active polypeptide of deer placenta
CN107674905A (en) Spirulina bioactive peptide, composition and preparation method
CN110915980A (en) Sunflower disc peptide powder, and preparation method and application thereof
CN1176204C (en) Mulberry vinegar and its production method
CN1067226C (en) Soybean peptide ammino acid oral liquid and its prepn
CN102247589A (en) Application of marine collagen peptide in preparing medicament and food for delaying skin aging
CN114213512B (en) Composition for enhancing photo-thermal stability of phycobiliprotein as well as preparation method and application thereof
CN107960629B (en) Seafood and shrimp-flavor soup jelly and preparation method thereof
CN1065875C (en) Fibrillating cell growth factor-2 analogue and its production method and use
CN1853656A (en) Fermentation composition having immunomodulating effect
CN1782067A (en) Process for synthesizing recombined human intestine trilobate factor using GS115 microzyme
CN111990652A (en) Ganoderma lucidum collagen peptide powder and preparation method thereof
CN111073944A (en) Directional preparation method of active peptide based on Caco-2 cell model
JPS60149528A (en) Extraction of active component from mycelium of fomes japonicus
KR102445696B1 (en) Processed boiled and steamed mature silkworm with improved absorption rate and the method thereof
CN101058595A (en) Ibonucleic acid, and preparation method and application thereof
CN1584044A (en) Preparing method for antler polypeptide or tortoise plastron polypeptide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20010425

Termination date: 20130831